Kyra / Clinical Intelligence
Connecting Conversations to Clinical Strategy
In the Pharma industry, data integrity is essential for effective decision-making, regulatory compliance, and business operations. Chryselys’ Data Anomaly Detection capability provides a robust framework to identify, analyze, and correct anomalies across both master and transactional
datasets.
By integrating AI-driven anomaly detection with statistical methodologies, we help Pharma companies eliminate data inconsistencies, reduce compliance risks, and enhance overall data quality.
Clinical trials are increasingly complex with rising costs, narrower eligibility criteria, and stricter timelines. KYRA – Clinical Intelligence simplifies this complexity. Built on Chryselys’ GenAI foundation, KYRA brings together structured trial data, unstructured scientific literature, and internal knowledge repositories to support faster, more informed clinical planning.
Traditional tools and dashboards often fall short of answering nuanced trial design questions. KYRA steps in to bridge this gap offering context-aware insights, tailored to the unique needs of each study.
Whether you’re looking to design an inclusion/exclusion framework, identify geographies with higher protocol fit, or analyze feasibility across trial arms, KYRA provides directional guidance grounded in data.
Define Study Parameters with Clarity
Get intelligent suggestions for inclusion/exclusion criteria and population design, based on a mix of historical trials, current literature, and benchmarked feasibility.
Assess Protocol Feasibility by Geography & Site
Understand how protocol criteria may impact enrollment across different geographies. KYRA helps identify bottlenecks in feasibility, suggest design modifications, and improve study viability.
Support Strategic Investigator Selection
Beyond databases and static filters, KYRA enables a deeper understanding of investigators—evaluating historical trial participation, patient access, protocol fit, and therapeutic relevance.
Generate Structured Knowledge from Unstructured Sources
KYRA combs through scientific literature, competitive intelligence, and trial registries to surface insights that usually remain hidden in PDFs and scattered repositories.
How It Works?
KYRA integrates trial registries (e.g., ClinicalTrials.gov), literature databases, sponsor-specific data, and feasibility benchmarks into a unified GenAI environment. A conversational interface allows cross-dataset querying with citations, evidence, and rationale included making KYRA not just an answer engine, but a strategic clinical planning companion.
Faster Trial Planning
Significantly reduce the time needed to design and iterate on protocol parameters.
Evidence-backed Decisions
Every suggestion comes with traceable references—improving confidence and compliance.
Enhanced Investigator Fit
Go beyond name-matching to assess true protocol alignment and access to patient cohorts.
Customizable for Your Needs
Tailor KYRA’s training data to reflect your organization’s priorities, therapeutic focus, and past trial learnings.
Speed to Market
Accelerate your trial start-up by addressing design and feasibility risks earlier in the planning cycle.
GenAI-Powered, Not Just Search-Enabled
KYRA is context-aware, responding with synthesized insights instead of keyword matches
Multi-source Integration
Combines internal and external data, structured and unstructured, without needing manual collation
Built with Pharma-Specific Prompts
Designed for trial planners, not general-purpose users
Built by Chryselys
Backed by deep pharma expertise, trial analytics experience, and a GenAI-first product vision
The voice of the field is not noise – it is intelligence.
KYRA – Clinical Intelligence helps you hear it clearly.
Let’s turn real-world conversations into real-world action
Revolutionize your business trajectory and achieve unprecedented growth with our committed partnership
Have Questions?